EDAP TMS S.A. Announces First Focal One® HIFU Treatments Performed In Germany

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LYON, France, May 6, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, reported the first Focal One HIFU treatments performed in Germany.

The Department of Urology at the Fuerth Hospital, Germany, headed by Dr. Andreas Blana, has recently initiated the use of the Focal One HIFU device for treatment of prostate cancer, on a mobile revenue per procedure (RPP) basis. Among the first patients treated with Focal One were three US patients who traveled to Germany to benefit from this non-invasive HIFU focal therapeutic approach.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC